Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study

AIM: To assesses the safety and efficacy of Aspergillus niger prolyl endoprotease (AN-PEP) to mitigate the immunogenic effects of gluten in celiac patients. METHODS: Patients with initial diagnosis of celiac disease as confirmed by positive serology with subtotal or total villous atrophy on duodenal...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tack, Greetje J, van de Water, Jolanda MW, Bruins, Maaike J, Kooy-Winkelaar, Engelina MC, van Bergen, Jeroen, Bonnet, Petra, Vreugdenhil, Anita CE, Korponay-Szabo, Ilma, Edens, Luppo, von Blomberg, B Mary E, Schreurs, Marco WJ, Mulder, Chris J, Koning, Frits
Formato: Artigo
Idioma:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2013
Assuntos:
Brief Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3793137/
https://ncbi.nlm.nih.gov/pubmed/24124328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i35.5837
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares